Filter posts

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …

On Drug Costs, “We All have Accountability and Responsibility”

The BIO 2017 convention is well underway, highlighting the innovative breakthroughs taking place across the …

“High Tech Enables High Touch.” Stanford’s Dean of Medicine on How Technology is Changing the ...

Dean Lloyd Minor says technology, and specifically, smartphones are making healthcare deliverable in real-time. By …

One Health Holds the Key to Preventing the Next Pandemic

Can we combat disease threats before they even emerge?  In the fight against infectious diseases, …

New BIO White Paper Outlines Policies to Better Combat Antimicrobial Resistance

In recent years, the global community has directed a high level of political attention to …

A Patient Advocate Perspective on BIO

As the mother of a 12-year-old son with hypophosphatasia, the BIO International Convention is much …

The Sarcoma Foundation of America, a Patient Advocacy Group for a Rare Cancer

The Sarcoma Foundation of America (SFA) is national cancer research non-profit headquartered in Maryland.  Founded …

A Cheat Sheet for Today’s Drug Price Hearing

The debate over drug pricing is heating up in various states across the country. But …

Taking on High-Risk Investments to Understand Brains and Solve Epilepsy

30 percent of people living with epilepsy do not have seizure control. Moreover, many can …

"How to Make Medicine More Expensive."

That’s the appropriate title of a Wall Street Journal editorial released earlier this week, which …